Statin use is associated with reduced mortality in patients with interstitial lung disease

PLoS ONE

Volumn 10, Issue 10, 2015, Pages

  Vedel Krogh, Signe ^a   Nielsen, Sune F ^a   Nordestgaard, Børge G ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; AZATHIOPRINE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; COLCHICINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; GLUCOCORTICOID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METHOTREXATE; MYCOPHENOLIC ACID; THALIDOMIDE; THEOPHYLLINE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CELL PROLIFERATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DANISH CITIZEN; DIABETES MELLITUS; DISEASE REGISTRY; FEMALE; FIBROBLAST; HAZARD RATIO; HUMAN; ICD-10; INTERSTITIAL LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROPENSITY SCORE; SENSITIVITY ANALYSIS; SURVIVAL TIME; COMPARATIVE STUDY; DENMARK; IDIOPATHIC PULMONARY FIBROSIS; LUNG DISEASES, INTERSTITIAL; MIDDLE AGED; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

AGED; DENMARK; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; IDIOPATHIC PULMONARY FIBROSIS; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84949211939     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0140571     Document Type: Article

References (35)

1. Bradley B, Branley HM, Egan JJ, Greaves MS, Hansell DM, Harrison NK et al. Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax. 2008; 63 Suppl 5: v1-58. doi: 10.1136/thx.2008.101691 PMID: 18757459
2. Bjoraker JA, Ryu JH, Edwin MK, Myers JL, Tazelaar HD, Schroeder DR et al. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 1998; 157: 199-203. PMID: 9445300
3. Lota HK, Wells AU. The evolving pharmacotherapy of pulmonary fibrosis. Expert Opin Pharmacother. 2013; 14: 79-89. doi: 10.1517/14656566.2013.758250 PMID: 23265249
4. Goldstein JL, Brown MS Regulation of the mevalonate pathway. Nature. 1990; 343: 425-430. PMID: 1967820
5. Van AL, D'Souza-Schorey C. Rho GTPases and signaling networks. Genes Dev. 1997; 11: 2295-2322. PMID: 9308960
6. Tan A, Levrey H, Dahm C, Polunovsky VA, Rubins J, Bitterman PB. Lovastatin induces fibroblast apoptosis in vitro and in vivo. A possible therapy for fibroproliferative disorders. Am J Respir Crit Care Med. 1999; 159: 220-227. PMID: 9872842
7. Watts KL, Cottrell E, Hoban PR, Spiteri MA. RhoA signaling modulates cyclin D1 expression in human lung fibroblasts; implications for idiopathic pulmonary fibrosis. Respir Res. 2006; 7: 88. PMID: 16776827
8. Albert MA, Danielson E, Rifai N, Ridker PM. Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study. JAMA. 2001; 286: 64-70. PMID: 11434828
9. Forrester JS, Libby P. The inflammation hypothesis and its potential relevance to statin therapy. Am J Cardiol. 2007; 99: 732-738. PMID: 17317382
10. Saad N, Camus P, Suissa S, Ernst P. Statins and the risk of interstitial lung disease: a cohort study. Thorax. 2013; 68: 361-364. doi: 10.1136/thoraxjnl-2012-201823 PMID: 23299962
11. Xu JF, Washko GR, Nakahira K, Hatabu H, Patel AS, Fernandez IE et al. Statins and pulmonary fibrosis: the potential role of NLRP3 inflammasome activation. Am J Respir Crit Care Med. 2012; 185: 547-556. doi: 10.1164/rccm.201108-1574OC PMID: 22246178
12. Fernandez AB, Karas RH, Alsheikh-Ali AA, Thompson PD. Statins and interstitial lung disease: a systematic review of the literature and of food and drug administration adverse event reports. Chest. 2008; 134: 824-830. doi: 10.1378/chest.08-0943 PMID: 18689579
13. Pedersen CB, Gotzsche H, Moller JO, Mortensen PB. The Danish Civil Registration System. A cohort of eight million persons. Dan Med Bull. 2006; 53: 441-449. PMID: 17150149
14. Andersen TF, Madsen M, Jorgensen J, Mellemkjoer L, Olsen JH. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull. 1999; 46: 263-268. PMID: 10421985
15. Sode BF, Dahl M, Nielsen SF, Nordestgaard BG. Venous thromboembolism and risk of idiopathic interstitial pneumonia: a nationwide study. Am J Respir Crit Care Med. 2010; 181: 1085-1092. doi: 10.1164/rccm.200912-1951OC PMID: 20167844
16. Nielsen SF, Nordestgaard BG, Bojesen SE. Statin use and reduced cancer-related mortality. N Engl J Med. 2012; 367: 1792-1802. doi: 10.1056/NEJMoa1201735 PMID: 23134381
17. Helweg-Larsen K. The Danish Register of Causes of Death. Scand J Public Health. 2011; 39: 26-29. doi: 10.1177/1403494811399958 PMID: 21775346
18. Donders AR, van der Heijden GJ, Stijnen T, Moons KG. Review: a gentle introduction to imputation of missing values. J Clin Epidemiol. 2006; 59: 1087-1091. PMID: 16980149
19. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med. 2002; 165: 277-304. PMID: 11790668
20. Nadrous HF, Ryu JH, Douglas WW, Decker PA, Olson EJ. Impact of angiotensin-converting enzyme inhibitors and statins on survival in idiopathic pulmonary fibrosis. Chest. 2004; 126: 438-446. PMID: 15302729
21. Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr., Kastelein JJ et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008; 359: 2195-2207. doi: 10.1056/NEJMoa0807646 PMID: 18997196
22. Bu DX, Tarrio M, Grabie N, Zhang Y, Yamazaki H, Stavrakis G et al. Statin-induced Kruppel-like factor 2 expression in human and mouse T cells reduces inflammatory and pathogenic responses. J Clin Invest. 2010; 120: 1961-1970. doi: 10.1172/JCI41384 PMID: 20440076
23. Sadowitz B, Maier KG, Gahtan V. Basic science review: Statin therapy-Part I: The pleiotropic effects of statins in cardiovascular disease. Vasc Endovascular Surg. 2010; 44: 241-251. doi: 10.1177/1538574410362922 PMID: 20403949
24. Varbo A, Benn M, Tybjaerg-Hansen A, Nordestgaard BG. Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation. Circulation. 2013; 128: 1298-1309. doi: 10.1161/CIRCULATIONAHA.113.003008 PMID: 23926208
25. Wang CY, Liu PY, Liao JK. Pleiotropic effects of statin therapy: molecular mechanisms and clinical results. Trends Mol Med. 2008; 14: 37-44. PMID: 18068482
26. Hothersall E, McSharry C, Thomson NC. Potential therapeutic role for statins in respiratory disease. Thorax. 2006; 61: 729-734. PMID: 16877692
27. Selman M, King TE, Pardo A. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med. 2001; 134: 136-151. PMID: 11177318
28. Lee JH, Lee DS, Kim EK, Choe KH, Oh YM, Shim TS et al. Simvastatin inhibits cigarette smokinginduced emphysema and pulmonary hypertension in rat lungs. Am J Respir Crit Care Med. 2005; 172: 987-993. PMID: 16002570
29. Fukumoto Y, Libby P, Rabkin E, Hill CC, Enomoto M, Hirouchi Y et al. Statins alter smooth muscle cell accumulation and collagen content in established atheroma of watanabe heritable hyperlipidemic rabbits. Circulation. 2001; 103: 993-999. PMID: 11181475
30. Bellosta S, Via D, Canavesi M, Pfister P, Fumagalli R, Paoletti R et al. HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophages. Arterioscler Thromb Vasc Biol. 1998; 18: 1671-1678. PMID: 9812903
31. Grip O, Janciauskiene S, Lindgren S. Atorvastatin activates PPAR-gamma and attenuates the inflammatory response in human monocytes. Inflamm Res. 2002; 51: 58-62. PMID: 11926313
32. Ryu JH, Daniels CE, Hartman TE, Yi ES. Diagnosis of interstitial lung diseases. Mayo Clin Proc. 2007; 82: 976-986. PMID: 17673067
33. Kao PN. Simvastatin treatment of pulmonary hypertension: an observational case series. Chest. 2005; 127: 1446-1452. PMID: 15821229
34. Kawut SM, Bagiella E, Lederer DJ, Shimbo D, Horn EM, Roberts KE et al. Randomized clinical trial of aspirin and simvastatin for pulmonary arterial hypertension: ASA-STAT. Circulation. 2011; 123: 2985-2993. doi: 10.1161/CIRCULATIONAHA.110.015693 PMID: 21593252
35. Dormuth CR, Patrick AR, Shrank WH, Wright JM, Glynn RJ, Sutherland J et al. Statin adherence and risk of accidents: a cautionary tale. Circulation. 2009; 119: 2051-2057. doi: 10.1161/CIRCULATIONAHA.108.824151 PMID: 19349320